STAT Plus: Vertex reports positive results in stem cell trial for type 1 diabetes
Vertex
Vertex Pharmaceuticals is a Boston-based biopharmaceutical company well-known for its groundbreaking work against cystic fibrosis, for its stellar financial performance, and for controversies surrounding drug pricing. It is currently researching treatments for sickle cell, chronic pain, muscular dystrophy, diabetes and more.
Latest
STAT Plus: Vertex reaches a new deal with NHS England over its pricey cystic fibrosis treatments
Listen: Vertex’s big deal, biotech’s red numbers, & an industry history lesson
STAT Plus: Vertex to buy Alpine Immune Sciences for $4.9 billion
STAT Plus: Vertex Pharmaceuticals is considering relocating its headquarters
Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an FDA icon
STAT Plus: Can gene therapies make for a profitable business? Keep your eye on Bluebird Bio
STAT Plus: Vertex pain drug results met with measured optimism — and questions — by observers and experts
All Coverage
advertisement
